Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

CMS proposal includes cardiologist pay bump—but concerns remain | ASNC pushes Congress for change | Vitamin D supplements & CVD

News You Need to Know Today
CMS proposal includes cardiologist pay bump—but concerns remain | ASNC pushes Congress for change | Vitamin D supplements & CVD
Wednesday, July 16, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. 

READ MORE >
Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.
Share on Twitter Share on Facebook Share on Linkedin

CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern

Share on Twitter Share on Facebook Share on Linkedin
Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.
The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. 
READ MORE >

ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

READ MORE >
Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC’s call on Congress for to reduce prior authorization, appropriate use mandates and to make Medicare payment reforms.
Share on Twitter Share on Facebook Share on Linkedin

ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

Share on Twitter Share on Facebook Share on Linkedin
Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC’s call on Congress for to reduce prior authorization, appropriate use mandates and to make Medicare payment reforms.
Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 
READ MORE >

Yes, researchers argue, vitamin D supplements help protect the heart

The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.

READ MORE >
vitamin d supplement heart health CVD
Share on Twitter Share on Facebook Share on Linkedin

Yes, researchers argue, vitamin D supplements help protect the heart

Share on Twitter Share on Facebook Share on Linkedin
vitamin d supplement heart health CVD
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.
READ MORE >

Featured Articles

FDA approves Bayer's finerenone to treat wide range of heart failure patients

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

READ MORE >
Bayer finerenone Kerendia heart failure MOONRAKER
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Bayer's finerenone to treat wide range of heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
Bayer finerenone Kerendia heart failure MOONRAKER
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
READ MORE >

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.
READ MORE >

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

READ MORE >
Ultromics EchoGo Amyloidosis artificial intelligence. A first of its kind AI model developed by Mayo Clinic and Ultromics Ltd., was found to be highly accurate in screening for cardiac amyloidosis in a large 2,612 patient clinical trial. The findings were published in the European Heart Journal.[1] Mayo Clinic, investigators at the University of Chicago Medicine and collaborators around the world at other sites, validated and tested the model on a large and multi-ethnic population.
Share on Twitter Share on Facebook Share on Linkedin

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

Share on Twitter Share on Facebook Share on Linkedin
Ultromics EchoGo Amyloidosis artificial intelligence. A first of its kind AI model developed by Mayo Clinic and Ultromics Ltd., was found to be highly accurate in screening for cardiac amyloidosis in a large 2,612 patient clinical trial. The findings were published in the European Heart Journal.[1] Mayo Clinic, investigators at the University of Chicago Medicine and collaborators around the world at other sites, validated and tested the model on a large and multi-ethnic population.
The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.
READ MORE >

Update to Johnson & Johnson PFA platform gains FDA approval

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

READ MORE >
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA
Share on Twitter Share on Facebook Share on Linkedin

Update to Johnson & Johnson PFA platform gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.
READ MORE >

In Case You Missed It

Female heart surgeons take home much lower salaries

Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Female heart surgeons take home much lower salaries

Share on Twitter Share on Facebook Share on Linkedin
women doctors
Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.
READ MORE >

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.

READ MORE >
Boston Scientific's Sentinel Cerebral Protection System during a TAVR procedure prevents emboli released from going to the brain and causing a stroke.
Share on Twitter Share on Facebook Share on Linkedin

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific's Sentinel Cerebral Protection System during a TAVR procedure prevents emboli released from going to the brain and causing a stroke.
Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.
READ MORE >

AI turns low-quality MRI scans into helpful heart images

A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans.

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

AI turns low-quality MRI scans into helpful heart images

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans.
READ MORE >

In Other News

Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging

LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. 

READ MORE >
Lantheus
Share on Twitter Share on Facebook Share on Linkedin

Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging

Share on Twitter Share on Facebook Share on Linkedin
Lantheus
LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. 
READ MORE >

AI and QI—a partnership made for healthcare

Within healthcare, artificial intelligence and quality improvement have some things in common. 

READ MORE >
quality improvement QI artificial intelligence AI healthcare
Share on Twitter Share on Facebook Share on Linkedin

AI and QI—a partnership made for healthcare

Share on Twitter Share on Facebook Share on Linkedin
quality improvement QI artificial intelligence AI healthcare
Within healthcare, artificial intelligence and quality improvement have some things in common. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Insulin pods recalled | Cardiology groups support bill | Treating ‘broken hearts’ | AI delivers answers | Prasugrel after PCI
The high costs of robotic tech | Medtronic recalls thousands of devices | TAVR in younger patients | FDA approves next-gen valve
Heart pump controllers recalled | Concomitant EP procedures for AFib | FDA's update after deaths | Pacing techniques & TAVR
The risks of PFA | FDA's warning after patient death | Cardiac ablations in ASCs | Group wants TAVR changes
How TAVR implant depth impacts outcomes | A closer look at GLP-1 drugs & AFib | BATMAN technique to the rescue
Week in Review: Reprocessed catheters recalled | New payment model almost here | 3-year SMART data | Hypertension drug approved

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup